Drug recall · August 27, 2025
Vial Label: 8.4% Sodium Bicarbonate Injection recall
Why: Lack of Assurance of Sterility.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Vial Label: 8.4% Sodium Bicarbonate Injection, USP, 50mEq/50 mL (1 mEq/mL), Rx only, Hospira, Inc., Lake Forest, IL 60045, USA, NDC 0409-6637-24. Case NDC: 00409-6637-14.
- Lots / codes
Lot #: LH2671, Exp. 11/30/2026
- Quantity
- 15,750 vials
- Company
- Pfizer Inc, New York, NY
- Distribution
- U.S. Nationwide
- Initiated
- August 4, 2025 · Voluntary: Firm initiated
- Classified
- August 18, 2025
- Reported
- August 27, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Sodium bicarbonate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.